Exploring the Influence of Chemical Exposures in Breast Cancer Disparities: High-Throughput Transcriptomic Analysis in Normal Breast Cells from Diverse Donors

This study utilizes high-throughput transcriptomic profiling of normal breast cells from diverse donors to demonstrate that exposure to specific environmental chemicals, particularly those with documented racial disparities, induces biological changes linked to aggressive breast cancer hallmarks, such as cell cycle dysregulation and altered cellular plasticity, at concentrations relevant to the US population.

The Gist

The Big Picture: Why Do Some Women Get Sicker?

Imagine breast cancer as a house fire. Some fires are small and easy to put out (less aggressive cancers), while others are massive, fast-moving infernos that are very hard to stop (aggressive cancers like Triple-Negative Breast Cancer).

The sad reality is that in the US, women of African ancestry are much more likely to get these "inferno" fires and die from them compared to other groups. Scientists have looked at genetics, diet, and lifestyle to explain this, but there's a missing piece of the puzzle: chemicals in our environment.

This study asks: Could the different chemicals women are exposed to in their daily lives be secretly turning up the volume on these dangerous fires?

The Experiment: A "Chemical Stress Test" for Breast Cells

To find the answer, the researchers didn't use mice or test tubes with just one type of cell. Instead, they used a high-tech approach they call a "Chemical Stress Test" on real human breast cells.

1. The Test Subjects: They took normal, healthy breast cells from 6 different women (3 African American, 3 European American). Think of these cells as the "foundation" of a house. Even though they are healthy, they carry the unique genetic "blueprint" of the woman they came from.
2. The Stressors: They exposed these cells to 8 different chemicals that are known to be found in higher amounts in the bodies of African American women due to environmental inequality. These included:
   • Heavy Metals: Like Lead, Cadmium, and Arsenic (think of these as rust and grime).
   • Organic Chemicals: Like BPA (plastics), PFNA (non-stick coatings), and DDE (a leftover from old pesticides).
3. The Doses: They didn't just dump a bucket of chemicals on them. They used three levels of exposure: a tiny sip, a moderate drink, and a heavy gulp. These levels were chosen to match what real people actually have in their blood and urine.

What Happened? (The Results)

1. Everyone Reacts Differently (The "Personalized" Factor)

Just like how some people get a headache from coffee while others don't, the cells reacted very differently based on who they came from.

• The Analogy: Imagine 6 different cars driving into a storm. One car might just get a little wet, while another might have its engine stall. The study found that who you are matters more than the chemical itself. Some women's cells were very sensitive, while others were tough.

2. The "Heavy Metal" Effect vs. The "Plastic" Effect

The researchers noticed a clear split between the two types of chemicals:

• Heavy Metals (Lead, Arsenic, Cadmium): These were like a sledgehammer. They caused massive, loud changes in the cells' instructions (genes) across almost everyone. They triggered the cells to start acting like cancer cells—growing too fast, ignoring stop signs, and becoming "plastic" (changing their shape to become more dangerous).
• Organic Chemicals (BPA, etc.): These were more like whispers. They caused changes, but they were quieter and varied wildly from person to person. Some women's cells ignored them; others reacted strongly.

3. The "Switch" to Cancer Mode

The most scary finding was that these chemicals didn't just make the cells sick; they flipped specific switches that are known to cause aggressive breast cancer.

• The "Mitotic Spindle" Switch: This is the machine cells use to copy themselves. The chemicals made this machine spin out of control, causing cells to multiply like crazy.
• The "Protein Secretion" Switch: This is how cells talk to each other. The chemicals made the cells shout confusing messages, which helps cancer spread.
• The "Stem Cell" Switch: The chemicals made normal cells act like "stem cells" (the raw material that can turn into anything). This is dangerous because stem cells are the ones that usually start the most aggressive tumors.

4. The "Real World" Connection

The researchers compared their lab results to data from the US government (NHANES), which tracks what chemicals are actually in people's bodies.

• The Verdict: For Lead, Copper, BPA, and DDE, the amount of chemical needed to cause these scary changes in the lab was the same amount found in the blood of average American women.
• The Metaphor: It's like finding out that the amount of smoke in a room that causes a fire alarm to go off is exactly the same as the smoke you get from a normal candle. The danger is happening at levels we consider "normal."

Why This Matters

This study is a wake-up call. It suggests that environmental injustice is literally changing our biology.

Because African American women are disproportionately exposed to these toxic chemicals (due to where they live, work, and the food they eat), their breast cells are being forced to adapt in dangerous ways. They are being pushed toward the "aggressive" type of cancer that is harder to treat.

The Takeaway

Think of your body as a garden. Some people's gardens are in a neighborhood with clean air and water. Others are in a neighborhood with toxic runoff. This study shows that even if you plant healthy seeds (healthy cells), the toxic runoff (chemicals) can force those seeds to grow into weeds (aggressive cancer).

The researchers are using this new, high-tech method to prove that we can't just treat cancer after it starts; we need to clean up the environment to stop the garden from getting poisoned in the first place.

Technical Summary

1. Problem Statement

Breast cancer disparities remain a critical public health issue, particularly regarding the higher incidence of aggressive subtypes (e.g., Triple-Negative Breast Cancer) and mortality rates among women of African ancestry compared to European American women. While factors like genetics and social determinants of health are well-studied, the role of environmental chemical exposures in driving these disparities is poorly characterized.

Previous studies have established that African American and low-income women face disproportionate exposure to toxicants (heavy metals, pesticides, PFAS, endocrine disruptors). However, existing risk models often rely on animal models or immortalized cell lines that fail to capture human genetic diversity and inter-individual variability. There is a need for New Approach Methodologies (NAMs) that utilize human primary tissues to determine if exposure disparities translate into biological changes relevant to aggressive breast cancer at human-relevant doses.

2. Methodology

The study employed a high-throughput, nested experimental design using Conditionally Reprogrammed (CR) normal human mammary epithelial cells.

• Sample Cohort: Six primary cell lines derived from nulliparous women (3 self-identified African American, 3 European American), matched by age, BMI, and menstrual cycle timing.
• Chemical Exposure: Eight chemicals with documented racial/ethnic exposure disparities were tested:
  • Heavy Metals: Cadmium, Lead, Arsenic, Copper.
  • Organic Compounds: Bisphenol A (BPA), Bisphenol S (BPS), p,p'-DDE (DDT metabolite), Perfluorononanoic acid (PFNA).
• Dosing Regimen: Three concentrations (0.1 µM, 1 µM, 10 µM) selected based on prior benchmark concentration modeling linking in vitro responses to NHANES population biomarker data.
• Assays:
  • Transcriptomics: Bulk RNA-sequencing (RNA-seq) using the plexWell 384-well plate-based method (Illumina NovaSeq).
  • Cytotoxicity: Parallel high-content imaging to assess cell viability (nuclei counts) to distinguish specific biological responses from non-specific cytotoxicity.
  • Bioinformatics:
    • Differential Expression: limma-voom with empirical Bayes moderation and permutation testing.
    • Pathway Analysis: Gene Set Enrichment Analysis (GSEA) using MSigDB Hallmark gene sets.
    • Dose-Response Modeling: Benchmark Dose (BMD) analysis using BMDExpress to determine concentrations causing a 1 SD change in gene expression.
    • Cell Deconvolution: MuSiC algorithm using a single-cell atlas of the normal breast to estimate shifts in myoepithelial vs. luminal progenitor cell proportions.
    • Clinical Correlation: Fisher's exact test comparing chemical-induced DEGs with genes associated with poor survival in The Cancer Genome Atlas (TCGA-BRCA) cohort.

3. Key Contributions

• Human-Relevant NAM: Demonstrates a scalable, high-throughput transcriptomic workflow using primary human cells from diverse genetic backgrounds, moving beyond standard cell lines.
• Disparity-Centric Design: Explicitly links chemicals with known racial exposure disparities to biological mechanisms of aggressive breast cancer.
• Integration of Multi-Omics Data: Combines transcriptomics, cytotoxicity, cell-type deconvolution, and epidemiological biomarker data (NHANES) to contextualize findings.
• Quantification of Inter-Individual Variability: Provides a granular view of how genetic background influences sensitivity to specific toxicants, highlighting that "average" responses may mask high-risk subgroups.

4. Key Results

A. Inter-Individual Variability Dominates Transcriptomic Landscape

• Donor Identity: Multidimensional scaling (MDS) revealed that donor identity was the primary driver of transcriptomic variation, outweighing chemical treatment or dose.
• Viability vs. Response: A weak negative correlation was found between cell viability and the number of differentially expressed genes (DEGs). 97% of conditions maintained >50% viability, confirming that observed transcriptional changes were biological responses rather than artifacts of cell death.

B. Chemical-Specific and Dose-Dependent Responses

• Heavy Metals (Arsenic, Lead, Cadmium, Copper): Induced the most robust and consistent transcriptional responses across all donors.
  • Arsenic and Lead consistently elicited significant DEGs across all doses and all six individuals.
  • Directionality: Lower doses often caused downregulation, while higher doses (10 µM) favored upregulation.
• Organic Compounds (BPA, BPS, DDE, PFNA): Showed more heterogeneous, individual-specific responses with fewer total DEGs.
  • BPA and BPS predominantly induced upregulated gene profiles.
  • PFNA showed minimal enrichment.

C. Pathway Enrichment and Hallmarks of Cancer

• Common Pathways: Across chemicals, pathways related to mitotic spindle assembly and protein secretion were commonly enriched.
• Heavy Metal Signatures: Metals strongly activated oncogenic pathways, including PI3K/AKT/mTOR signaling, oxidative stress response (e.g., HMOX1, ALDH family), and pro-inflammatory signaling (IL6, TNF).
• Organic Compound Signatures: Bisphenols (BPA/BPS) showed unique metabolic shifts, including upregulation of glycolysis and hypoxia response, alongside downregulation of MYC targets and oxidative phosphorylation.
• Cell Plasticity: Bioinformatic deconvolution revealed that Cadmium induced a shift toward myoepithelial enrichment, while Lead increased luminal progenitor fractions. Arsenic showed biphasic effects. These shifts suggest chemical-induced alterations in cellular plasticity, a hallmark of cancer.

D. Relevance to Human Exposure and Clinical Outcomes

• NHANES Comparison: Benchmark Dose (BMD) modeling showed that for BPA, p,p'-DDE, Copper, and Lead, the concentrations required to induce transcriptomic changes overlapped with or were lower than biomarker concentrations found in the general US population (NHANES data).
• TCGA Survival Correlation: Heavy metals (Lead, Arsenic, Cadmium, Copper) induced gene expression changes that significantly overlapped with genes associated with poor breast cancer survival in the TCGA-BRCA cohort. Organic compounds did not show this significant enrichment.

5. Significance

This study provides mechanistic evidence that environmental chemicals with known racial exposure disparities can drive biological processes associated with aggressive breast cancer (e.g., metastasis, stemness, survival signaling) at concentrations relevant to the US population.

• Mechanistic Insight: It identifies specific pathways (mitotic spindle, protein secretion, PI3K/AKT/mTOR) that are dysregulated by toxicants, potentially explaining the biological basis for higher mortality rates in exposed populations.
• Public Health Implication: The findings support the hypothesis that environmental exposures contribute to breast cancer disparities, particularly through heavy metal toxicity.
• Regulatory Impact: The study validates high-throughput transcriptomics in primary human cells as a powerful tool for chemical hazard assessment, aligning with modern regulatory shifts (e.g., FDA Modernization Act 2.0) away from animal testing toward human-relevant models.
• Future Directions: The authors highlight the need for longitudinal studies and organ-on-chip models to capture chronic, low-dose exposures and further investigate the interplay between genetic ancestry and chemical susceptibility.